Fig. 1From: Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemiaPrognostic impact of the CDKN2A/ARF/CDKN2B gene CNV status and MRD levels (≤ 0.01 %) on overall survival (OS) of adult T-ALL patients (n = 62). a OS for patients with follow-up censored at allo-HSCT. b The OS without censoring at allo-HSCTBack to article page